Clinical efficacy evaluation of traditional Chinese medicine fumigation therapy in the treatment of rheumatoid arthritis with cold and dampness obstruction

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300077294

Enrollment

Unknown

Registered

2023-11-03

Start date

2022-04-04

Completion date

Unknown

Last updated

2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(rheumatoid arthritis)

Interventions

experimental group:Local fumigation with traditional Chinese medicine prescription

control group:Methotrexate tablets combined with leflunomide tablets for oral treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic standards of traditional Chinese medicine and Western medicine; ? The age ranges from 18 to 75; (3) Volunteer to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: ? Advanced patients with severe joint deformity and joint function grade ?; ? Combined with other organ or system diseases, such as Sjogren's syndrome, systemic lupus erythematosus, etc.; ? Allergic to drug ingredients; (4) Patients with serious diseases of heart, brain, liver, kidney and hematopoietic system.

Design outcomes

Primary

Measure	Time frame
Criteria for the efficacy of TCM syndromes;	—

Secondary

Measure	Time frame
Joint functional activity;Visual analogue scale;HAQ-DI;RF;	—

Countries

China

Contacts

Public Contactzengbowen

Jiangxi Provincial People's Hospital

529696604@qq.com+86 159 0708 0231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026